When the Gas Fails: Common Pitfalls in Ethylene Oxide (EO) Sterilization

Ethylene oxide (EO) remains the backbone of medical device sterilization, treating approximately 50% of all sterile medical devices globally. Its strength lies in material compatibility—it penetrates complex geometries, lumens, and polymers without melting plastics or degrading delicate electronics like high-heat autoclaving or gamma radiation can.

Molecule of ethylene oxide

However, EO sterilization is not a set-it-and-forget-it process. It is a finely balanced chemical reaction with narrow operating windows. A failure in any single process variable can compromise patient safety, cause regulatory halts, or damage high-value inventory.

Here is an engineering and quality breakdown of what can go wrong during an EO sterilization cycle—and why it matters.

1. The Humidity Deficit (Desiccation)

Of all the parameters in an EO cycle, relative humidity (RH) is the most deceptively fragile.

EO destroys microorganisms via alkylation, replacing hydrogen atoms within microbial DNA and protein chains with hydroxyethyl groups. For this reaction to occur, microbial spores (such as Bacillus atrophaeus) must be sufficiently hydrated.

• The Failure: If pre-conditioning fails to achieve the target humidity (typically 40% to 80% RH), bacterial spores desiccate. Desiccated spores form a hardened, crystalline outer structure that ethylene oxide gas cannot easily penetrate.

• The Result: The cycle completes normally according to pressure and temperature graphs, but the biological indicators (BIs) test positive for growth post-cycle.

Microorganisms seen under the microscope

2. Inadequate Pre-Conditioning and Temperature Gradients

EO cycles rely on elevated temperatures—usually between 37°C and 63°C (99°F to 145°F)—to drive diffusion and kill kinetics.

• Cold Spots in the Load: Pallets packed tightly with dense packaging (such as dense drapes or heavy polymer housings) act as thermal heat sinks. If a pallet has not spent enough time in pre-conditioning cells, the center of the pallet may lag behind chamber temperature by several degrees.

• The Result: Reaction rates drop significantly with every degree below target. Gas entering a cold zone can also condense prematurely, leading to localized liquid pooling instead of uniform vapor diffusion.

3. Gas Concentration of ethylene oxide and Chamber Leakage

Achieving the required lethal dose depends directly on maintaining stable gas concentration throughout the exposure dwell phase (typically 250 to 800 mg/L).

• Micro-leaks and Seal Degradation: Door gaskets, vacuum valves, and pipe unions deteriorate under cyclic thermal stress and repeated chemical exposure. A failing door seal causes pressure drift during the dwell phase.

• Vaporizer Inefficiencies: If the liquid EO is not completely vaporized before chamber entry, cold liquid droplets enter the chamber, creating uneven distribution and potential product scorching or polymer degradation.

• Dilution Errors: When using EO mixed with carrier gases (like CO2 or nitrogen to suppress flammability), improper blending or stratification can lead to sub-lethal concentrations inside the load core.

4. Packaging and Pallet Configuration Roadblocks

Sterilization does not happen to a bare device; it happens to a packaged device inside a carton, stacked on a pallet, wrapped in film.

• Breathability Mismatch: EO packaging requires a gas-permeable barrier (typically spunbound polyethylene like Tyvek® or medical-grade paper). If heat seals fail, or if adhesive zones are over-applied and block the porous surface, the gas exchange rate plummets.

• Over-Wrapping: Wrapping pallets too tightly in non-perforated stretch wrap prevents vacuum evacuation and stalls gas displacement.

• Pressure-Induced Seal Rupture: During rapid deep-vacuum evacuation or nitrogen pulsing, high pressure differentials between the inside of a blister pouch and the chamber can blow out sterile packaging seals—rendering the product non-sterile upon chamber exit.

Pallet of products ready for sterilisation

5. Aeration and Residual Outgassing Failures

A successful microbial kill is only half the battle. Because EO is a mutagen and known carcinogen, devices must undergo prolonged aeration to remove residual Ethylene Oxide (EO) and its reaction by products, Ethylene Chlorohydrin (ECH) and Ethylene Glycol (EG).

• Polymer Absorption: Soft, porous materials like PVC, silicone, and polyurethane act like sponges for EO.

• Insufficient Aeration Cycles: If the aeration cell lacks adequate air exchanges, heating, or dwell time, residual limits specified by ISO 10993-7 will be exceeded.

• Patient Hazard: High residuals can lead to tissue irritation, hemolysis, or systemic toxicity when the medical device contacts circulating blood or mucosal tissue.

At-a-Glance: Failure Mode & Impact Matrix

Process Stage	Root Cause	Visible / Detectable Failure
Pre-Conditioning	Dry room conditions or short dwell	Biological Indicator (BI) failure due to desiccated spores
Evacuation	Excessive vacuum ramp speed	Burst pouch seals, pinholes in Tyvek®
Gas Injection	Vaporizer malfunction or line chill	Liquid EO droplet staining, polymer crazing
Dwell Phase	Cold spots in dense pallet centers	Incomplete kill at core BIs; non-uniform alkylation
Post-Vacuum / Flushes	Faulty vacuum pump or leaky relief valve	Incomplete gas removal before aeration
Aeration	Low cell airflow, cool room, dense PVC content	Failed ISO 10993-7 chemical residual limits (EO/ECH)

If you want to know more about sterilisation by EO come and visit us at www.mdsspro.com.

Don't miss on our EO sterilisation training sterilization by EO course | MDSSPRO.